Thessaaloniki
Indication: Canine bacterial infections treated with ampicillin
Population PK simulator for ampicillin, an aminopenicillin beta-lactam antibiotic that inhibits bacterial cell-wall synthesis. Uses a two-compartment IV dog model with creatinine and anesthesia covariates to evaluate exposure and fT>MIC target attainment for veterinary infections.
Drug Overview
Clinical Context
- Molecular Target
- Beta-lactam fT>MIC target attainment
- Drug Class
- Aminopenicillin beta-lactam antibiotic
- Therapeutic Area
- Veterinary infectious disease
- Indication
- Canine bacterial infections treated with ampicillin
- Route of Administration
- Intravenous
Model Information
- Model Type
- Two-compartment population PK
This simulator was built from published pharmacometric literature using PKPDBuilder's AI-powered model extraction pipeline.
About This Simulator
This interactive pharmacokinetic simulator for Thessaaloniki allows you to explore concentration-time profiles under different dosing scenarios. The underlying Two-compartment population PK model characterizes the pharmacokinetics of this aminopenicillin beta-lactam antibiotic following intravenous administration.
Use the simulator to visualize key exposure metrics including AUC (area under the curve), Cmax (peak concentration), and Ctrough (trough concentration).
Built with PKPDBuilder — an AI-powered platform that transforms published pharmacometric literature into interactive, deployable Shiny applications. No coding required.
Frequently Asked Questions
What is the Thessaaloniki PK simulator?
This is a free, interactive pharmacokinetic simulator for Thessaaloniki used in Canine bacterial infections treated with ampicillin. It allows researchers, pharmacologists, and students to explore concentration-time profiles, dosing regimens, and exposure metrics based on published population PK models.
What drug class does Thessaaloniki belong to?
Thessaaloniki is classified as a Aminopenicillin beta-lactam antibiotic that targets Beta-lactam fT>MIC target attainment. It is used in the Veterinary infectious disease therapeutic area.
What route of administration does this model simulate?
This simulator models Intravenous administration of Thessaaloniki. The pharmacokinetic parameters (absorption rate, bioavailability, volume of distribution) are specific to this route.
What type of PK model is used?
This simulator uses a Two-compartment population PK model. This model characterizes the time-course of drug concentrations following dosing.
Is this simulator free to use?
Yes, all PKPDBuilder simulators are completely free. They are built from published pharmacokinetic literature and are intended for research and educational purposes. No login is required to run simulations.
Can I use this for clinical dosing decisions?
No. This simulator is for research and educational purposes only. It should not be used for clinical decision-making or patient dosing. Always consult the prescribing information and clinical pharmacology guidelines for therapeutic drug use.
Ready to Simulate?
Launch the Thessaaloniki simulator to explore dosing scenarios and pharmacokinetic profiles interactively.
🚀 Launch SimulatorComments
⚠️ Disclaimer
This simulator is for research and educational purposes only. It is not intended for clinical decision-making, patient dosing, or therapeutic drug monitoring. Pharmacokinetic parameters are derived from published literature and represent population-level estimates. Individual patient pharmacokinetics may differ significantly. Always consult approved prescribing information and qualified healthcare professionals for clinical decisions.
Powered by PKPDBuilder.com • Free pharmacokinetic simulators for the scientific community